Positioning of nootropics in the national market
Keywords:nootropics, marketing research, common market
Peptides of vasopressin stimulating the processes of study and memory are situated between the most perspective nootropics.
The aim of work is forming an informational file about medicines with nootropic action and determination of the actuality and advisability of new drugs development, basing on the marketing research of nootropics domestic market.
Materials and methods. Internet-base of State register of drugs, Compendium and State logbook of medicines.
Results. Analysis of modern state of nootropics showed that assortment of medicines belonging to this group and having influence on memory improvement is very limited. Home-made drugs with nootropic action containing peptides of vasopressin aren’t registered.
Conclusions. Research of modern domestic market of nootropics allowed to establish that on the modern stage at this segment inUkraine 24 active substances from the list of international nonproprietary names of World Health Organization are registered and presented by 107 commercial names. At the same time in quantitative expression home-made medicines are prevailed but the main profit is provided by the imported nootropics. It is established that oral dosage forms (pills and capsules) are the main nootropics used in domestic practical medicine. Applicative dosage forms with nootropic active pharmaceutical ingredients inUkraine are absent. Cerebrolysin, piracetam, phenotropil are the leaders of price rating of nootropics sale. Considering the low level of bioavailability of active pharmaceutical ingredients at oral route of administration the research for creating of original pharmacotherapeutic medications for alternative transmucosal application of appropriate dosage forms (nasal ointments) on the base of peptides of vasopressin will allow to create nootropic drugs providing with high efficacy and maximal minimization of side effects and adequate by the indexes of paying capacity.
Datsko, O. I. (2013). Importozamishchennia u farmatsevtychnii haluzi yak priopitet stratehii sotsialnoi bezpeky [Substituting for an import in pharmaceutical industry as priority of strategy of social safety]. Sotsialna farmatsiia v Ukraini: stan, problemy ta perspektyvy Proceedings of the All-Ukrainian Scientific and Practical Internet-Conference, (pp. 109–120). Kharkiv: NFU. [in Ukrainian].
Nakaz MOZ Ukrainy «Pro zatverdzhennia Kontseptsii rozvytku farmatsevtychnoho sektoru haluzi okhorony zdorovia» vid 13.09.2010 roku №769 [An order of Ministry of health Ukraine is «About claim of Conception of development of pharmaceutical sector of industry of guard of здоровя Ukraine on 2011–2020» from September 13, 2010 №769] Retrieved from http://moz.gov.ua/ua/portal/dn_20100913_769. html. [in Ukrainian].
Yastrebov, V. S., Mitikhina, I. A., & Mitikhin, V. G., Shevchenko, L. S., & Solokhina, T. A. (2012). Psikhicheskoe zdorov'e naseleniya mira: social'no-e'konomicheskij aspect (po dannym zarubezhnykh issledovanij 2000–2010 gg.) [Psychical health of population of the world : social and economic aspect (from data of foreign researches 2000–2010)]. Zhurnal nevrologii i psikhiatrii, 2, 4–13. [in Russian].
Potupchik, T. V., Veselova, O. F., & E'vert, L. S. (2014). Farmakodinamicheskie aspekty primeneniya nekotorykh nootropnykh sredstv pri kognitivnykh narusheniiakh [Pharmacological dynamic aspects of application of some nootrop facilities at kognitive violations]. Farmateka, 13(286), 45–55. [in Russian].
Kamchatnov, P. R., Vorob'eva, O. R., & Rachin, A. P. (2014). Korrekciya e'mocional'nykh i kognitivnykh narushenij u pacientov s khronicheskoj ishemiej golovnogo mozga [Correction of emotional and kognitive violations for patients with a chronic cerebral ischemia]. Zhurnal nevrologii i psikhiatrii im S.S. Korsakova, 4, 52–56. [in Russian].
Alvarez, X. A., Figueroa, J., & Muresanu, D. (2013). Peptidergicheskie sredstva v lechenii travmaticheskogo povrezhdeniya golovnogo mozga [Peptidergias of mean in treatment of traumatic damage of cerebrum]. Mizhnarodnyi nevrolohichnyi zhurnal, 3, 92–104. [in Russian].
Stuchlík, A., Petrásek, T., Prokopová, I., Holubová, K., Hatalová, H., Valeš, K., et al. (2013). Place avoidance tasks as tools in the behavioral neuroscience of learning and memory]. Physiol. Res., 62(1), 1–19.
Belyakova, A. S., Sinjushin, A. A., Voskresenskaya, O. G., Golubovich, V. P., & Kamensky, A. A. (2017). Vliyanie sinteticheskogo analoga fragmenta arginin-vazopressina na process obucheniya krys [Influence of the synthetic analog of the arginine-vasopressin fragment on rat training]. Vesci Nacyyanal'naj akademii navuk Belarusi. Seryya medycynskikh navuk, 2, 104–116. [in Russian].
Abedinova, A. L., & Kanata, S. P. (2018). Ocenka, stepeni e'mocional'nogo vygoraniya i vliyanie ego pokazatelej na urovni vrazhdebnosti i agressivnosti u studentov-medikov vtorogo kursa [Estimation of degree of the emotional burning down and influence of his indexes on the levels of hostility and aggressiveness for the students of physicians of the second course]. Obzory po klinicheskoj farmakologii i lekarstvennoj terapii, 2(16), 133–134. [in Russian].
Kirichek, L. T., Perepelica, A. V. & Kalchuk, R. O. (2016). Lekarstvennyi antistress v e'ksperimente (immobilizaciya, travma, vospalenie) [Medicinal antistress is in an experiment (immobilization, trauma, inflammation)]. Kharkiv: Kontrast. [in Russian].
Kompendium [Compendium]. Retrieved from http://compendium.com.ua [in Ukrainian].
Derzhavnyi formuliar likarskykh zasobiv [State formular of medications]. Retrieved from https://www.moz.gov.ua/ua/portal/ [in Ukrainian].
Kryvoviaz, O. V. (2013). Marketynhovyi analiz rynku likarskykh zasobiv dlia likuvannia hlaukomy [Research of domestic market of medicines for treating glaucoma]. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii., 1, 51–55. [in Ukrainian].
Glushchenko, A. V., Georgiyants, V. A., & Valigura, Y. G. (2014). Analitychnyi ohliad farmatsevtychnoho rynku suchasnykh hepatoprotektornykh preparativ [The analytical review of pharmaceutical market of the modern hepatoprotective drugs]. Farmatsevtychnyi zhurnal, 4, 17–23. [in Ukrainian].
Rudenko, V. V., Shmatenko, O. P., Prytula, R. L., & Maksymuk, T. M. (2012). Analiz farmatsevtychnoho rynku likarskykh zasobiv hrupy d06 antibiotyky i khimioterapevtychni preparaty dlia zastosuvannia v dermatolohii [The study of pharmaceutical market of antibiotic and chemotherapeutic agents for use in dermatology]. Visnyk farmatsii, 4, 66–70. [in Ukrainian].
How to Cite
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)